The nominations for this year's The Pathologist Power List are open.
03/11/2021 | Sponsored by Thermo Fisher Scientific
In this webinar, our speakers will discuss the benefits of CGP and how this technique is utilized in their lab.
02/24/2021 | Sponsored by Aurora mScope Inc.
The field of digital pathology (DP) continues to see ongoing innovation, growth and development.
02/18/2021 | Sponsored by Akoya Biosciences
In this webinar, the speakers will describe how they used multiplexed imaging and single-cell analysis to study the immune response to the SARS-CoV-2 virus across multiple organ systems.
01/13/2021 | Sponsored by Akoya Biosciences
Optimisation and validation of a multiplex immunofluorescence workflow, from staining to digital image analysis, ensures assay robustness and prepares this technology for deployment in clinical trial analysis and in routine diagnostics.
12/14/2020 | Sponsored by Promega
Microsatellite Instability (MSI)-High has been identified as a biomarker for immune checkpoint inhibitor therapy in cancers originating in different tissues.
12/09/2020 | Sponsored by Roche
An increasing number of clinical laboratories are using next generation sequencing (NGS) for the molecular characterization of cancer.
12/02/2020 | Sponsored by Invitae
ArcherDX , now Invitae is a leading genomics company democratizing precision oncology.
11/11/2020 | Sponsored by Paige
Prostate cancer, the most frequently diagnosed cancer in 105 countries and the leading cause of death in 46 countries worldwide, is diagnosed by core needle biopsy.
11/04/2020 | Sponsored by Adaptive Biotechnologies
clonoSEQ® Assay is a highly sensitive, specific, and standardized method for detecting and monitoring minimal residual disease (MRD).
10/01/2020 | Sponsored by QIAGEN
Targeted NGS has been instrumental in driving our understanding of disease.
09/26/2020
The Pathologist is delighted to introduce the Pathologists’ Assistants: Bridging the Gap Live Roundtable.
09/23/2020 | Sponsored by Thermo Fisher Scientific
The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
To Screen, or not to Screen?
Women in Pathology
The Matchmakers